JP2001521744A - 乳房の疾患の検出に有用な試薬および方法 - Google Patents

乳房の疾患の検出に有用な試薬および方法

Info

Publication number
JP2001521744A
JP2001521744A JP2000519086A JP2000519086A JP2001521744A JP 2001521744 A JP2001521744 A JP 2001521744A JP 2000519086 A JP2000519086 A JP 2000519086A JP 2000519086 A JP2000519086 A JP 2000519086A JP 2001521744 A JP2001521744 A JP 2001521744A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
polynucleotide
sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000519086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521744A5 (https=
Inventor
ビリング−メデル，パトリシア・エイ
コーエン，モーリス
コルピツツ，トレイシー・エル
フリードマン，ポーラ・エヌ
ゴードン，ジユリアン
グラナドス，エドワード
ホツジス，ステイーブン・シー
クラス，マイクル・アール
クラトクビル，ジヨン・デイー
ロバーツ−ラツプ，ライザ
ラツセル，ジヨン・シー
ストロープ，ステイーブン・デイー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2001521744A publication Critical patent/JP2001521744A/ja
Publication of JP2001521744A5 publication Critical patent/JP2001521744A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2000519086A 1997-10-31 1998-10-19 乳房の疾患の検出に有用な試薬および方法 Pending JP2001521744A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96209497A 1997-10-31 1997-10-31
US08/962,094 1997-10-31
PCT/US1998/022020 WO1999023230A1 (en) 1997-10-31 1998-10-19 Reagents and methods useful for detecting diseases of the breast

Publications (2)

Publication Number Publication Date
JP2001521744A true JP2001521744A (ja) 2001-11-13
JP2001521744A5 JP2001521744A5 (https=) 2006-01-05

Family

ID=25505413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000519086A Pending JP2001521744A (ja) 1997-10-31 1998-10-19 乳房の疾患の検出に有用な試薬および方法

Country Status (4)

Country Link
EP (1) EP1027444A1 (https=)
JP (1) JP2001521744A (https=)
CA (1) CA2308029A1 (https=)
WO (1) WO1999023230A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024003255A (ja) * 2013-08-14 2024-01-11 ジェン－プローブ・インコーポレーテッド Ｈｅｖ核酸を検出するための組成物および方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US6365348B1 (en) 1997-12-24 2002-04-02 Corixa Corporation Compounds for diagnosis of Breast cancer and methods for their use
US6649342B1 (en) 1999-03-15 2003-11-18 Eos Biotechnology, Inc. Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US6316272B1 (en) 1999-03-15 2001-11-13 Eos Biotechnology, Inc. Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators
EP1159619A2 (en) * 1999-03-15 2001-12-05 EOS Biotechnology, Inc. Methods of diagnosing and treating breast cancer
US20040141983A1 (en) 1999-03-15 2004-07-22 Protein Design Labs, Inc. Compositions against cancer antigen LIV-1 and uses thereof
US6762020B1 (en) 1999-03-15 2004-07-13 Protein Design Labs, Inc. Methods of diagnosing breast cancer
WO2001035811A2 (en) * 1999-11-16 2001-05-25 Eos Biotechnology, Inc. Methods of diagnosing and determining prognosis of breast cancer
US6780586B1 (en) 1999-11-29 2004-08-24 Protein Design Labs, Inc. Methods of diagnosing breast cancer
JP2004503208A (ja) * 2000-02-29 2004-02-05 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
WO2004067564A2 (en) 2003-01-29 2004-08-12 Protein Design Labs, Inc. Compositions against cancer antigen liv-1 and uses thereof
US20110004085A1 (en) 2009-04-30 2011-01-06 Dexcom, Inc. Performance reports associated with continuous sensor data from multiple analysis time periods
EP2648752B1 (en) 2010-12-06 2017-02-15 Seattle Genetics, Inc. Humanized antibodies to liv-1 and use of same to treat cancer
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby
MX2018010847A (es) 2016-03-15 2019-07-04 Seattle Genetics Inc Terapia combinada mediante el uso de un conjugado de anticuerpo-farmaco de liv1 (liv1-adc) y agente quimioterapeutico.
US10054485B2 (en) 2016-03-17 2018-08-21 Raytheon Company UV LED-phosphor based hyperspectral calibrator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4614472B2 (ja) * 1996-10-31 2011-01-19 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
JP2001522239A (ja) * 1997-03-21 2001-11-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ８７個のヒト分泌タンパク質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024003255A (ja) * 2013-08-14 2024-01-11 ジェン－プローブ・インコーポレーテッド Ｈｅｖ核酸を検出するための組成物および方法

Also Published As

Publication number Publication date
WO1999023230A1 (en) 1999-05-14
CA2308029A1 (en) 1999-05-14
EP1027444A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
EP0939824B1 (en) Reagents and methods useful for detecting diseases of the breast
US20050255519A1 (en) Reagents and methods useful for detecting diseases of the prostate
JP2001521744A (ja) 乳房の疾患の検出に有用な試薬および方法
WO1999025877A1 (en) Reagents and methods useful for detecting diseases of the breast
EP0954599A1 (en) Reagents and methods useful for detecting diseases of the prostate
CA2284686A1 (en) Reagents and methods useful for detecting diseases of the gastrointestinal tract
WO1999002714A1 (en) Reagents and methods useful for detecting diseases of the breast
EP0870025B1 (en) Reagents and methods useful for detecting diseases of the breast
JP2002512513A (ja) 胃腸管の疾患の検出に有用な試薬および方法
US6183952B1 (en) Reagents and methods useful for detecting diseases of the breast
US20030130492A1 (en) Reagents and methods useful for detecting diseases of the breast
CA2292843A1 (en) Reagents and methods useful for detecting diseases of the breast
CA2293661A1 (en) Reagents and methods useful for detecting diseases of the breast
EP0856010A1 (en) Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
US20020037503A1 (en) Reagents and methods useful for detecting diseases of the breast
EP0972056A1 (en) Reagents and methods useful for detecting diseases of the lung
US20020034740A1 (en) Reagents and methods useful for detecting diseases of the breast
WO1998044160A1 (en) Reagents and methods useful for detecting diseases of the gastrointestinal tract
US20050214848A1 (en) Reagents and methods useful for detecting diseases of the breast
WO1999022027A1 (en) Reagents and methods useful for detecting diseases of the breast
US20020045165A1 (en) Reagents and methods useful for detecting diseases of the breast
US20030104364A1 (en) Reagents and methods useful for detecting diseases of the breast
CA2358748A1 (en) Reagents and methods useful for detecting diseases of the breast
US20040072210A1 (en) Reagents and methods useful for detecting diseases of the breast
US20020188115A1 (en) Reagents and methods useful for detecting diseases of the breast

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050810

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050810

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080826

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090210